Influenza vaccination with PREFLUCEL: vaccination motivation and tolarability

• Conditions: Influenza prophylaxis in adults and older persons; J11.1; Influenza with other respiratory manifestations, virus not identified

• Registration Number: DRKS00003253
• Lead Sponsor: Baxter Deutschland GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-09-07
• Study Completion: 2011-11-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 298

Inclusion Criteria

Patients who have been vaccinated with PREFLUCEL for influenza prophylaxis and who signed a written informed consent to participate in this non-interventional study.

Exclusion Criteria

no exclusion criteria

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identify methods for motivating patients for influenza vaccination in practices: once per site on a separate questionnaire. <br>Collect patients' motivation and indication for influenza vaccination: once in the CRF. <br>Document the tolerability of the PREFLUCEL vaccination after about 4 weeks in the CRF.